Atlas Trials

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Melanoma (Morpheus-Melanoma)

Clinical trial NCT05116202 · COMPLETED

Trial details

NCT number
NCT05116202
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2022-02-02
Primary completion
2023-09-22
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.